Fluvoxamine affects sildenafil kinetics and dynamics

Journal of Clinical Psychopharmacology

Volumn 25, Issue 6, 2005, Pages 589-592

  Hesse, Christiane ^a   Siedler, Heike ^a   Burhenne, Jürgen ^a   Riedel, Klaus Dieter ^a   Haefeli, Walter E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE MALEATE; NITROPRUSSIDE SODIUM; PLACEBO; SILDENAFIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXPOSURE; DRUG HALF LIFE; DRUG TOLERABILITY; FLUSHING; HAND; HEADACHE; HUMAN; HUMAN EXPERIMENT; KINETICS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; VEIN COMPLIANCE; VEIN DILATATION;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FLUVOXAMINE; HAND; HUMANS; MALE; NITROPRUSSIDE; PIPERAZINES; REFERENCE VALUES; VASODILATION; VASODILATOR AGENTS; VEINS;

EID: 27944503509     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000186866.82665.29     Document Type: Article

References (19)

1. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-1404.
2. Corbin JD, Francis SH. Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem. 1999;274:13729-13732.
3. Cheitlin MD, Hutter AM Jr, Brindis RG, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol. 1999;33:273-282.
4. Dishy V, Sofowora G, Harris PA, et al. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin Pharmacol Ther. 2001;70:270-279.
5. Warrington JS, Shader RI, von Moltke LL, et al. In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Drug Metab Dispos. 2000;28:392-397.
6. Muirhead GJ, Wulff MB, Fielding A, et al. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol. 2000;50:99-107.
7. Vella JP, Sayegh MH. Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis. 1998;31:320-323.
8. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry. 2003;64(suppl 10):5-10.
9. Dorevitch A, Davis H. Fluvoxamine-associated sexual dysfunction. Ann Pharmacother. 1994;28:872-874.
10. Rosenberg KP. Sildenafil citrate for SSRI-induced sexual side effects. Am J Psychiatry. 1999;156:157.
11. Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil. A randomized controlled trial. JAMA. 2003;289:56-64.
12. Aellig WH. A new technique for recording compliance of human hand veins 1981. Br J Clin Pharmacol. 2004;58:768-774.
13. Fricker R, Hesse C, Weiss J, et al. Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br J Clin Pharmacol. 2004;58:169-177.
14. Nurnberg HG, Duttagupta S. Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use. Am J Ther. 2004;11:9-12.
15. Fleishaker JC, Hulst LK. A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine. Eur J Clin Pharmacol. 1994;46:35-39.
16. Lam YW, Alfaro CL, Ereshefsky L, et al. Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. J Clin Pharmacol. 2003;43:1274-1282.
17. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther. 2002;71:21-29.
18. Wilner K, Laboy L, LeBel M. The effects of cimetidine and antacid on the pharmacokinetic profile of sildenafil citrate in healthy male volunteers. Br J Clin Pharmacol. 2002;53(1):31S-36S.
19. Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol. 2002;53(1):5-12.